SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001513160-13-000040
Filing Date
2013-07-25
Accepted
2013-07-25 17:23:42
Documents
4
Period of Report
2013-07-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 GENESIS BIOPHARMA CURRENT REPORT gnbp8k07242013.htm 8-K 46317
2 AGREEMENT AND PLAN OF MERGER ex101.htm EX-10.1 141171
3 FORM OF GENESIS DIRECTOR STOCK AWARD AGREEMENT ex102.htm EX-10.2 30235
4 PRESS RELEASE ISSUED JULY 25, 2013 ex991.htm EX-99.1 12901
  Complete submission text file 0001513160-13-000040.txt   232060
Mailing Address 1601 N. SEPULVEDA BLVD., #632 MANHATTAN BEACH CA 90266
Business Address 1601 N. SEPULVEDA BLVD., #632 MANHATTAN BEACH CA 90266 866-963-2220
Genesis Biopharma, Inc (Filer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: NV | Fiscal Year End: 0528
Type: 8-K | Act: 34 | File No.: 000-53127 | Film No.: 13987260
SIC: 4731 Arrangement of Transportation of Freight & Cargo